American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary.
暂无分享,去创建一个
Irl B Hirsch | Kenneth L Jones | Lois Jovanovič | Philip Levy | Faramarz Ismail-Beigi | Lawrence Blonde | Kenneth L. Jones | G. Bray | I. Hirsch | H. Lebovitz | L. Jovanovič | K. Wyne | G. Grunberger | F. Ismail-Beigi | L. Blonde | A. Vinik | E. Horton | A. Garber | J. Mechanick | Z. Bloomgarden | D. Einhorn | O. Ganda | Y. Handelsman | P. Jellinger | J. Davidson | P. Levy | S. Dagogo-Jack | E. Orzeck | Samuel Dagogo-Jack | George A Bray | Yehuda Handelsman | Zachary T Bloomgarden | Jeffrey I Mechanick | George Grunberger | Jaime A Davidson | Daniel Einhorn | Om Ganda | Alan J Garber | Edward S Horton | Paul S Jellinger | Harold Lebovitz | Etie S Moghissi | Eric A Orzeck | Aaron I Vinik | Kathleen L Wyne | E. Moghissi
[1] Mary T Korytkowski,et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[2] B. Ammori,et al. Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis , 2010, Expert opinion on pharmacotherapy.
[3] H. Rodbard,et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[4] Neil J Stone,et al. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.
[5] R. Collins,et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. , 2009, Lancet.
[6] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[7] J. Ge,et al. Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis. , 2010, Diabetes research and clinical practice.
[8] T. Danne,et al. Foreword: DAWN Youth – time to make a real difference , 2009, Pediatric diabetes.
[9] Kenneth L. Jones,et al. Medical writer , 2019, Combatting Burnout.
[10] H. Gharib,et al. American Association of Clinical Endocrinologists Protocol for Standardized Production of Clinical Practice Guidelines--2010 update. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[11] T. Davis,et al. Aspirin Is Associated With Reduced Cardiovascular and All-Cause Mortality in Type 2 Diabetes in a Primary Prevention Setting , 2009, Diabetes Care.